secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2023-05-10T23:59:59+00:00
Accession:  0001217234-23-000094
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx Q1 revenue $77.3M (-3% YoY); withdraws 2023 guidance on billing article uncertainty
--------------------------------------------------------------------------------

- Record test volumes 49,900 (AlloMap/AlloSure), up 17% YoY; testing services revenue $61.8M.
- GAAP net loss $23.7M ($0.44 loss per share); adjusted EBITDA loss $6.4M.
- Patient & Digital Solutions revenue $8.6M, up 39% YoY; cash $285.9M, no debt.
- Withdrew 2023 revenue guidance due to MolDX Billing Article revisions in March and May 2023.
- Delayed submission of ~$8.9M in AlloSure Kidney Medicare tests from Q1 to Q2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723423000094/0001217234-23-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723423000094/cdna-20230510.htm
  HTML page:      https://secwatch.observer/filing/0001217234-23-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer